Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements), By Region, And Segment Forecasts, 2019 - 2026

Industry Insights

The global parenteral nutrition market size was valued at USD 5.3 billion in 2018 and is expected to exhibit a CAGR of 5.8% over the forecast period. Presence of a large number of malnourished children, high natality rate around the globe, increasing premature births, rising occurrence of cancer, which requires administration of vital nutrients to increase hydration, energy, and strength of cancer patients, and rising adoption by healthcare settings for administration of nutrients in chronically ill geriatric patients are driving the market.

Malnutrition is one of the major drivers in the parenteral nutrition market. As per the UNICEF, poor nutrition to infants in their initial 1,000 days may lead to impaired cognitive ability and stunted growth. An infant’s diet must contain a proper balance of vitamins, minerals, amino acids, starch, and lipids. These vital nutrients can be administered via parenteral nutrition, which is estimated to propel the market growth.

Furthermore, the American Society for Parenteral and Enteral Nutrition (ASPEN) recognized the increasing risk of malnourishment in about 30-50% of the hospitalized patients leading to increasing costs and readmission rates. To educate and raise awareness among patients and healthcare providers, the institute launched the malnutrition awareness week.

Individuals and healthcare authorities are paying extensive focus on limiting the mortality rate due to early birth and are thereby propelling the use of parenteral nutrition. The premature birth rate of U.S. is around 9.6%, as of 2016, and the national authorities are working to decrease it to 8.1% as stated by the National Center for Healthcare Statistics. Hence, a large number of neonates requiring supplementary nutrition post birth is expected to boost the market demand over the forecast period.

According to the World Health Organization (WHO), around 14.0 billion new cases of mortality due to cancer were accounted in 2014. The organization also stated that about 70.0% increase in cancer diagnosis may be expected by 2025, which is anticipated to fuel the market growth. Hence, the market is anticipated to be driven by increasing population base of cancer-induced anemia patients.

Increasing occurrence of chronic conditions, such as cancer, influences the usage of parenteral nutrition around the globe. The benefit of parenteral nutrition is that it helps in the administration of vital nutrients that help in maintaining the hydration level, energy, and strength in cancer patients, therefore acting as a vital impact rendering driver anticipated to surge market growth throughout the forecast period.

Nutrient Type Insights

Single dose amino acid solutions held a substantial share in 2018. Increased use of amino acid solutions can be credited to increase in the influx of regulatory approved solutions. Besides, newly available solutions of amino acid possess fewer side effects, thus enhancing patient benefits.

Parenteral lipid emulsion has potential benefits as a drug delivery vehicle due to which it is expected to witness the highest growth. It is mainly used for the administration of drugs that prevent thrombophlebitis and reduce irritation and pain. Lipid emulsions are also prescribed for pediatric patients as they are a non-carbohydrate source of energy in low osmolarity and volume. These lipid emulsions are also useful in maintaining net nitrogen balance in parenteral nutrition solutions. Moreover, these are a rich source of essential fatty acids.

Regional Insights

North America dominated the overall market in 2018, owing to presence of high research expenditure by government agencies and private entities in the healthcare sector, technologically advanced medical devices, and collaborations among regulatory authorities, medical device industry, and universities. Moreover, rising occurrence of several chronic diseases, existence of advanced healthcare facilities, as well as favorable reimbursement policies have led to an increase in the hospital admission that is anticipated to boost the usage rates in this region.

Asia-Pacific is projected to witness lucrative growth throughout the forecast period. Economic development in nations such as China, India, and Japan, along with favorable government initiatives related to the development of healthcare infrastructure and reimbursement policies, is further anticipated to fuel market growth. Besides, growing Foreign Direct Investment (FDI) in the medical devices and healthcare sectors by various private and government organizations are expected to provide incentives for manufacturing technologically-advanced products over the forecast period.

Parenteral Nutrition Market Share Insights

Some of the key market players operating in the industry are Baxter International Inc.; Grifols International S.A.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; and Hospira Inc. These companies are actively involved in improving the current product portfolio of parenteral nutrition to sustain their position in the market. Moreover, development of new drugs and their entry in the untapped regions are estimated to boost the market growth. For instance, in 2016, Baxter International received marketing authorization for its product NUMETA G13E from the competent authorities in U.K. and Denmark.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research, Inc. has segmented the global parenteral nutrition market report on the basis of nutrient type and region:

• Nutrient Type Outlook (Revenue, USD Million, 2015 - 2026)

  • Carbohydrates

  • Lipid Emulsion

  • Single Dose Amino Acid Solution

  • Trace Elements

  • Vitamins & Minerals

• Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • Italy

    • France

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE